TB006 clinical trials
Also written TB006.
How each study uses TB006 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the TB006 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- TB006
- 7
Studies by the year they started
7 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 1
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test TB006.
- Nov 2026A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseasePhase 2 · TrueBinding, Inc.
- Dec 2026TB006 for Autism Spectrum DisorderPhase 2 · Rossignol Medical Center
Studies
Open first, then newest update. How each study uses TB006 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- TB006 for Autism Spectrum DisorderRecruitingPhase 2Rossignol Medical CenterNCT06500637Written as TB006
- A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's DiseaseTerminatedPhase 2TrueBinding, Inc.NCT05476783Written as TB006
- A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseaseActive, not recruitingPhase 2TrueBinding, Inc.NCT06773962Written as TB006
- Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy SubjectsCompletedPhase 1TrueBinding, Inc.NCT04920786Written as TB006
- A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic StrokeWithdrawnPhase 2TrueBinding, Inc.NCT05156827Written as TB006
- Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's DiseaseCompletedPhase 1/2TrueBinding, Inc.NCT05074498Written as TB006
- Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19WithdrawnPhase 1TrueBinding, Inc.NCT04801056Written as TB006
Codes
What other systems call TB006 · ClinicalTrials.gg INT001588
- MeSH (NLM) C000715407TB006One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000715407 | TB006 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.